Search research articles
Contact Us
Filters
Showing results (151-160 of 169) with videos related to
Page
of 17
Sort By:
Biochemical Society Transactions
|
August 28, 2002
Specific 14-3-3 isoform detection and immunolocalization in prion diseases
H C Baxter, J R Fraser, W-G Liu, et al.
Neuropathology and Applied Neurobiology
|
March 29, 2000
Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus
M Jeffrey, W G Halliday, J Bell, et al.
Journal of Crohn'S & Colitis
|
December 22, 2021
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]
Esther Ventress, David Young, Sohail Rahmany, et al.
Inflammatory Bowel Diseases
|
May 18, 2007
Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype
J R Fraser Cummings, Tariq Ahmad, Alessandra Geremia, et al.
Tissue Antigens
|
April 21, 2010
The genetics of NOD-like receptors in Crohn's disease
J R Fraser Cummings, R M Cooney, G Clarke, et al.
The Lancet. Infectious Diseases
|
April 28, 2023
Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial
Nathan J Brendish, Kate R Beard, Ahalya K Malachira, et al.
Connective Tissue Research
|
January 1, 1986
The catabolic fate of hyaluronic acid
T C Laurent, I M Dahl, L B Dahl, et al.
Australian and New Zealand Journal of Medicine
|
February 1, 1986
Arbovirus infection in a Murray Valley community
J R Fraser, D G Christie, I D Gust, et al.
BMJ Open Gastroenterology
|
January 23, 2026
Research engagement and patient-reported quality of care: a cross-sectional study of UK inflammatory bowel disease services
Robert J Mulligan, Pat Ryan, Lauren C Beck, et al.
Therapeutic Advances in Gastroenterology
|
July 30, 2025
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS study
Frederick Taylor, Giorgio Bartalucci, Catherine Gleave, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 169) with videos related to
Sort By:
Page
of 17
Biochemical Society Transactions
|
August 28, 2002
Specific 14-3-3 isoform detection and immunolocalization in prion diseases
H C Baxter, J R Fraser, W-G Liu, et al.
Neuropathology and Applied Neurobiology
|
March 29, 2000
Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus
M Jeffrey, W G Halliday, J Bell, et al.
Journal of Crohn'S & Colitis
|
December 22, 2021
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]
Esther Ventress, David Young, Sohail Rahmany, et al.
Inflammatory Bowel Diseases
|
May 18, 2007
Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype
J R Fraser Cummings, Tariq Ahmad, Alessandra Geremia, et al.
Tissue Antigens
|
April 21, 2010
The genetics of NOD-like receptors in Crohn's disease
J R Fraser Cummings, R M Cooney, G Clarke, et al.
The Lancet. Infectious Diseases
|
April 28, 2023
Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial
Nathan J Brendish, Kate R Beard, Ahalya K Malachira, et al.
Connective Tissue Research
|
January 1, 1986
The catabolic fate of hyaluronic acid
T C Laurent, I M Dahl, L B Dahl, et al.
Australian and New Zealand Journal of Medicine
|
February 1, 1986
Arbovirus infection in a Murray Valley community
J R Fraser, D G Christie, I D Gust, et al.
BMJ Open Gastroenterology
|
January 23, 2026
Research engagement and patient-reported quality of care: a cross-sectional study of UK inflammatory bowel disease services
Robert J Mulligan, Pat Ryan, Lauren C Beck, et al.
Therapeutic Advances in Gastroenterology
|
July 30, 2025
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS study
Frederick Taylor, Giorgio Bartalucci, Catherine Gleave, et al.
Page
of 17